Tumor cells in search for glutamate: An alternative explanation for increased invasiveness of IDH1 mutant gliomas

Neuro-Oncology

Volumn 16, Issue 12, 2014, Pages 1669-1670

  Van Lith, Sanne A M ^a   Molenaar, Remco ^b   Van Noorden, Cornelis J F ^b   Leenders, William P J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EXCITATORY AMINO ACID TRANSPORTER 2; GLUTAMATE DEHYDROGENASE; GLUTAMIC ACID; ISOCITRATE DEHYDROGENASE 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; ISOCITRATE DEHYDROGENASE;

BLOOD BRAIN BARRIER; CANCER PROGNOSIS; CELL METABOLISM; CELL PROLIFERATION; EXTRACELLULAR MATRIX; GLIOMA; HUMAN; LETTER; SIGNAL TRANSDUCTION; STEADY STATE; TUMOR CELL; TUMOR GROWTH; TUMOR INVASION; TUMOR MICROENVIRONMENT; WHITE MATTER; BRAIN TUMOR; GENETICS; GLIOBLASTOMA; PATHOLOGY;

BRAIN NEOPLASMS; GLIOBLASTOMA; HUMANS; ISOCITRATE DEHYDROGENASE;

EID: 84929512832     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/nou152     Document Type: Letter

References (8)

1. Baldock AL, Yagle K, Born DE, et al. Invasion and proliferation kinetics in enhancing gliomas predict IDH1 mutation status. Neuro Oncol. 2014;16(6):779-786.
2. Dang L, White DW, Gross S, et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature. 2009;462(7274):739-744.
3. Scott JG, Basanta D, Chinnaiyan P, et al. Production of 2-hydroxyglutarate by isocitrate dehydrogenase 1-mutated gliomas: an evolutionary alternative to the Warburg shift?. Neuro Oncol. 2011;13(12):1262-1264.
4. Molenaar RJ, Radivoyevitch T, Maciejewski JP, et al. The driver and passenger effects of isocitrate dehydrogenase 1 and 2 mutations in oncogenesis and survival prolongation. Biochim Biophys Acta. 2014. pii: S0304-419X (14) 00049-3.
5. Wise DR, Thompson CB. Glutamine addiction: a new therapeutic target in cancer. Trends Biochem Sci. 2010;35(8):427-433.
6. Van Lith SA, Navis AC, Verrijp K, et al. Glutamate as chemotactic fuel for diffuse glioma cells: Are they glutamate suckers? Biochimica et biophysica acta. 2014;1846(1):66-74.
7. Ziskin JL, Nishiyama A, Rubio M, et al. Vesicular release of glutamate from unmyelinated axons in white matter. Nat Neurosci. 2007;10(3):321-330.
8. De Groot JF, Liu TJ, Fuller G, et al. The excitatory amino acid transporter-2 induces apoptosis and decreases glioma growth in vitro and in vivo. Cancer Res. 2005;65(5):1934-1940.